State-of-the-art lecture on prediction and management of cardiovascular risk in cancer patients

Back

ESC Professional Premium Access

State-of-the-art lecture on prediction and management of cardiovascular risk in cancer patients

Session: Prediction and management of cardiovascular risk for patients with cancer

Topic: Cardio-Oncology

Speaker: Doctor A. Lyon (London, GB)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Alexander Lyon

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)

42 presentations

18 followers

4 more presentations in this session

Androgen deprivation therapy for prostate cancer, measures of adiposity and strength, and adverse cardiovascular outcomes: observations from 3000 men in 5 countries in the RADICAL PC study

Speaker: Doctor D. Leong (Hamilton, CA)

Risk prediction model of cardiotoxicity in breast cancer patients; the multicenter prospective CHECK HEART-BC (comprehensive heart imaging to evaluate cardiac damage linked with chemotherapy in breast

Speaker: Doctor Y. Terui (Sendai, JP)

Right ventricular free wall strain and tricuspid annular plane systolic excursion for the prediction of left sided cardiotoxicity in lymphoma patients treated with anthracycline-based chemotherapy.

Speaker: Doctor C. Ricaurte Carmona (Rochester, US)

Clinical features and long-term outcomes of cancer-associated venous thromboembolism: transition from the warfarin era to the direct oral anticoagulant era

Speaker: Doctor R. Chatani (Kurashiki, JP)

Access the full session

Prediction and management of cardiovascular risk for patients with cancer

Speakers: Doctor A. Lyon, Doctor D. Leong, Doctor Y. Terui, Doctor C. Ricaurte Carmona, Doctor R. Chatani

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

State-of-the-art lecture on prediction and management of cardiovascular risk in cancer patients

About the speaker

Doctor Alexander Lyon

4 more presentations in this session

Androgen deprivation therapy for prostate cancer, measures of adiposity and strength, and adverse cardiovascular outcomes: observations from 3000 men in 5 countries in the RADICAL PC study

Risk prediction model of cardiotoxicity in breast cancer patients; the multicenter prospective CHECK HEART-BC (comprehensive heart imaging to evaluate cardiac damage linked with chemotherapy in breast

Right ventricular free wall strain and tricuspid annular plane systolic excursion for the prediction of left sided cardiotoxicity in lymphoma patients treated with anthracycline-based chemotherapy.

Clinical features and long-term outcomes of cancer-associated venous thromboembolism: transition from the warfarin era to the direct oral anticoagulant era

Access the full session

Prediction and management of cardiovascular risk for patients with cancer

About the event

ESC Congress 2023

ESC 365 is supported by